Trial | NCT01293734  Report issue

Title

Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    theophylline budesonide ...

  • Study Participants

    360
Bronchial asthma is a common disease and frequently encountered disease of respiratory apparatus. It has very complex mechanism and multiple inducing factors. This study will focus on a new Chinese therapy on Bronchial asthma, analyzing the treatment mechanism of internal and external use, based on Traditional Chinese Medicine (TCM) theory and clinical practice. The study will also investigate the efficacy of the Chinese drugs and treatments on Bronchial asthma, and provide an effective therapy for this disease.
Study Started
Dec 31
2008
Primary Completion
Jan 31
2011
Study Completion
Feb 28
2011
Last Update
Feb 11
2011
Estimate

Other warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum

warming lung and relieving asthmatic granule:once 1 bag, 3 times a day. Securing origin and warming lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day

Other clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum

clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day

Other securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum

securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day

Drug Theophylline Sustained-release Tablets and budesonide suspension

Theophylline Sustained-release Tablets 0.2g a time, twice a day. budesonide suspension for inhalation 100ug, twice a day

cold type Experimental

To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in cold type

heat type Experimental

To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in heat type.

Asthenia type Experimental

To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome in Asthenia type.

Western medicine control group Active Comparator

Criteria 

Inclusion Criteria:

Age between 18 to 65 years old;
Patients with mild-to-moderate bronchial asthma on attacking stage;
Without cardiopulmonary or other complications;
To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome differentiation;
Informed consent form is required to be signed.

Exclusion Criteria:

Older than 65 years or younger than 18 years old;
Pregnant woman or suckling period woman;
Patients combine serious primary disease in liver, renal, cardiovascular and cerebrovascular, hemopoietic system diseases,or psychosis.
Severe levels of disease is between severe and critical extent. Combine Pulmonary Heart Disease or respiratory failure;
Irritable the physique, or allergic to the given composition of drugs in this research;
Patients who are in the process of other clinical research.
No Results Posted